The prevalence of diabetes is increasing worldwide year by year. In developed countries, it has been listed as the third major disease following cardiovascular diseases and cancer. The greatest harm of diabetes lies in its various chronic complications, such as diabetic foot, diabetic nephropathy, diabetic retinopathy, and neuropathy, which have attracted great attention in the medical community. As we all know, prevention is better than treatment for any disease, and diabetes is no exception. Therefore, we should attach importance to diabetes screening among high-risk groups. So, who needs diabetes screening?
Individuals with a history of impaired glucose regulation;
People aged 45 years or older;
Overweight or obese individuals (BMI ≥ 24 kg/m²), with waist circumference ≥ 90 cm for men and ≥ 85 cm for women;
First‑degree relatives of patients with type 2 diabetes;
Women with a history of macrosomia (birth weight ≥ 4 kg) delivery or gestational diabetes mellitus;
Patients with hypertension (blood pressure ≥ 140/90 mmHg) or those receiving antihypertensive treatment;
Patients with dyslipidemia (HDL‑C ≤ 0.91 mmol/L (≤ 35 mg/dL) and/or TG ≥ 2.22 mmol/L (≥ 200 mg/dL)), or those receiving lipid‑lowering treatment;
Patients with cardiovascular and cerebrovascular diseases;
Individuals with a history of glucocorticoid‑induced diabetes;
Patients with polycystic ovary syndrome (PCOS) with BMI ≥ 28 kg/m²;
Patients with severe mental illness and/or those receiving long‑term antidepressant medication;
People with a sedentary lifestyle.